Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial of hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Loma Linda University | Conditions: Ovarian Cancer | Phase 1 | Status: COMPLETED